AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

TELIX PHARMACEUTICALS LTD

26.800

+0.1800.68%

Volume:1.11M

Turnover:29.80M

Market Cap:9.06B

PE:185.34

High:27.170

Open:26.880

Low:26.360

Close:26.620

Loading ...

Overview Company News Filings

Australian shares dragged by miners and gold stocks, set for weekly loss

Australia Shares Rise Despite Disappointing US Tech Earnings; Qantas Posts Higher Fiscal H1 Revenue, Earnings

MT Newswires Live

Telix Pharmaceuticals CEO, Co-Founder Sells Shares

MT Newswires Live

Telix Pharmaceuticals Ltd - CEO to Sell 2 Mln Shares

THOMSON REUTERS

Telix Pharmaceuticals Obtains US FDA Priority Review for Cancer Imaging Agent

MT Newswires Live

BRIEF-Telix Pharmaceuticals Says Tiffany Olson To Be Appointed Board Chair

Telix Pharmaceuticals Names New Board Chair

MT Newswires Live

FDA Accepts Bla for Tlx250-Cdx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review

THOMSON REUTERS

BRIEF-Telix Pharmaceuticals Says FDA Accepts BLA And Grants Priority Review For Zircaix

FDA Accepts Bla for Tlx250-Cdx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review

THOMSON REUTERS

Telix Pharmaceuticals Ltd - FDA Accepts Bla and Grants Priority Review for Zircaix

THOMSON REUTERS

Telix Pharmaceuticals Ltd - Tiffany Olson to Be Appointed Board Chair

THOMSON REUTERS

Telix Pharmaceuticals Ltd - H Kevin Mccann Ao Will Retire as Board Chairman

THOMSON REUTERS

Recruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical NOW Active in Miami

THOMSON REUTERS

Illuccix® Prostate Cancer Imaging Agent Approved in Luxembourg

THOMSON REUTERS

Telix Pharmaceuticals Shifts Reporting Currency to US Dollars; Shares Hit All-Time High

MT Newswires Live

BRIEF-Telix Pharmaceuticals Announces Change In Reporting Currency To USD

Telix Pharmaceuticals Ltd - Telix Announces Change in Reporting Currency to USD

THOMSON REUTERS

BUZZ-Telix up as Norway approves its prostate cancer imaging agent

Telix Pharmaceuticals Limited (TLX) Upgraded to Buy: What Does It Mean for the Stock?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TLX.AU/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","market":"AU","secType":"STK","nameCN":"TELIX PHARMACEUTICALS LTD","latestPrice":26.8,"timestamp":1746771120000,"preClose":26.62,"halted":0,"volume":1111086,"delay":0,"nameEN":"TELIX PHARMACEUTICALS LTD","floatShares":274906865,"shares":337878497,"eps":0.1446,"marketStatus":"Market Closed","change":0.18,"latestTime":"05-09 16:12:00 AEST","open":26.88,"high":27.17,"low":26.36,"amount":29801371,"amplitude":0.030428,"askPrice":26.83,"askSize":8954,"bidPrice":26.76,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":0.1446,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1747008000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":26.62,"openAndCloseTimeList":[[1746748800000,1746770400000]],"volumeRatio":0.6589934372030005,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","floatShares":274906865,"roa":"5.33%","roe":"13.92%","lyrEps":0.150709,"volumeRatio":0.6589934372030005,"shares":337878497,"dividePrice":0,"high":27.17,"amplitude":0.030428,"preClose":26.62,"low":26.36,"week52Low":14.42,"pbRate":"15.94","psRate":"11.56","week52High":31.97,"institutionHeld":0,"latestPrice":26.8,"committee":-0.713029,"eps":0.1446,"divideRate":0,"volume":1111086,"delay":0,"ttmEps":0.1446,"open":26.88,"prevYearClose":24.61,"prevWeekClose":29.32,"prevMonthClose":27.13,"prevQuarterClose":26.52,"fiveDayClose":29.32,"twentyDayClose":24.81,"sixtyDayClose":27.75},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX.AU\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514357071","title":"Australian shares dragged by miners and gold stocks, set for weekly loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2514357071","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514357071?lang=en_us&edition=fundamental","pubTime":"2025-02-28 08:17","pubTimestamp":1740701839,"startTime":"0","endTime":"0","summary":"Australian shares dragged by miners and gold stocks, set for weekly loss Feb 28 (Reuters) - Australian shares fell on Friday and were on track to post a weekly loss, dragged by mining and gold stocks ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL3N3PI2IJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7129","LU1064927863.SGD","BK7095","LU0266512127.USD","IE00BQJZX424.USD","SG9999002521.SGD","LU0456854461.SGD","LU0831103253.SGD","LU0612318385.USD","LU1130305938.SGD","LU0075056555.USD","BK7067","LU0345780950.USD","LU0011963245.USD","TLX.AU","BK7104","NST.AU","BK7511","LU0171293334.USD","LU0654597011.USD","SG9999001143.SGD","BK7135","FMG.AU","LU0788109121.HKD","BHP.AU","LU0612318971.USD","BK5111","LU0345781412.USD","LU0505663152.USD","LU0898667661.SGD","RIO.UK","LU0630314457.HKD","BK7506","LU0345777659.USD","LU0330918003.SGD","LU1078025761.USD","LU0345777147.USD","EVN.AU","IE00BWDBJ516.SGD","LU1430597077.USD","IE0034235071.USD","BK7507","LU1023059493.AUD","IE00B3M56506.USD","CBA.AU","LU0955669360.SGD"],"gpt_icon":0},{"id":"2514844545","title":"Australia Shares Rise Despite Disappointing US Tech Earnings; Qantas Posts Higher Fiscal H1 Revenue, Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2514844545","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514844545?lang=en_us&edition=fundamental","pubTime":"2025-02-27 14:05","pubTimestamp":1740636332,"startTime":"0","endTime":"0","summary":"Australian shares rose on Thursday's close despite technology firm Nvidia's quarterly earnings failing to deliver market expectations.The S&P/ASX 200 Index rose 0.3% or 27.5 points to close at 8,268.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XKO.AU","QAN.AU","COL.AU","XJO.AU","TLX.AU","XAO.AU"],"gpt_icon":0},{"id":"2514153088","title":"Telix Pharmaceuticals CEO, Co-Founder Sells Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2514153088","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514153088?lang=en_us&edition=fundamental","pubTime":"2025-02-27 09:26","pubTimestamp":1740619619,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  received notice that its Chief Executive Christian Behrenbruch sold 2 million shares in the company at AU$29.50 per share by way of a block trade, according to a Thursday Australian bourse filing.Behrenbruch now holds shares equal to about 6.3% of the company's issued capital and has no intention to sell them, the filing said.Additionally, the company's co-founder Andreas Kluge sold 2 million shares in the company for the same price.Company shares were down nearly 2% in recent Thursday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","TLX.AU","TLX"],"gpt_icon":0},{"id":"2514008035","title":"Telix Pharmaceuticals Ltd - CEO to Sell 2 Mln Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2514008035","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514008035?lang=en_us&edition=fundamental","pubTime":"2025-02-26 14:07","pubTimestamp":1740550052,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PG14J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","TLX.AU"],"gpt_icon":0},{"id":"2514073043","title":"Telix Pharmaceuticals Obtains US FDA Priority Review for Cancer Imaging Agent","url":"https://stock-news.laohu8.com/highlight/detail?id=2514073043","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514073043?lang=en_us&edition=fundamental","pubTime":"2025-02-26 10:57","pubTimestamp":1740538643,"startTime":"0","endTime":"0","summary":"The US Food and Drug Administration has accepted Telix Pharmaceuticals'  Biologics License Application for its investigational kidney cancer imaging agent TLX250-CDx, and granted a priority review that would pave the way for a commercial launch within the year, according to a Wednesday filing with the Australian bourse.The imaging agent has been given a Prescription Drug User Fee Act  date of Aug. 27. A PDUFA date provides an estimated timeline of when a decision on a drug application would be made.TLX250-CDx is said to be the first commercially available imaging agent to accurately and non-invasively diagnose and characterize clear cell renal cell carcinoma, a form of kidney cancer, per the filing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TLX.AU","TLX","BK7067"],"gpt_icon":0},{"id":"2514020976","title":"BRIEF-Telix Pharmaceuticals Says Tiffany Olson To Be Appointed Board Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2514020976","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514020976?lang=en_us&edition=fundamental","pubTime":"2025-02-26 10:03","pubTimestamp":1740535426,"startTime":"0","endTime":"0","summary":"BRIEF-Telix Pharmaceuticals Says Tiffany Olson To Be Appointed Board ChairFeb 26 (Reuters) - Telix Pharmaceuticals Ltd TLX.AX:TIFFANY OLSON TO BE APPOINTED BOARD CHAIRH KEVIN MCCANN AO WILL RETIRE AS ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PG162:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TLX.AU"],"gpt_icon":0},{"id":"2514209790","title":"Telix Pharmaceuticals Names New Board Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2514209790","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514209790?lang=en_us&edition=fundamental","pubTime":"2025-02-26 10:03","pubTimestamp":1740535405,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals (ASX:TLX) said Kevin McCann will retire as its chairman on May 21, and Tiffany Olson will be the successor, according to a Wednesday Australian bourse filing.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","XKO.AU","TLX","XJO.AU","TLX.AU","XAO.AU","BK4139"],"gpt_icon":0},{"id":"2514021027","title":"FDA Accepts Bla for Tlx250-Cdx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2514021027","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514021027?lang=en_us&edition=fundamental","pubTime":"2025-02-26 09:02","pubTimestamp":1740531745,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nTUA67ZL9S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLX.AU","BK7067"],"gpt_icon":0},{"id":"2514210290","title":"BRIEF-Telix Pharmaceuticals Says FDA Accepts BLA And Grants Priority Review For Zircaix","url":"https://stock-news.laohu8.com/highlight/detail?id=2514210290","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514210290?lang=en_us&edition=fundamental","pubTime":"2025-02-26 09:01","pubTimestamp":1740531665,"startTime":"0","endTime":"0","summary":"BRIEF-Telix Pharmaceuticals Says FDA Accepts BLA And Grants Priority Review For ZircaixFeb 26 (Reuters) - Telix Pharmaceuticals Ltd TLX.AX:FDA ACCEPTS BLA AND GRANTS PRIORITY REVIEW FOR ZIRCAIXFurther company coverage: TLX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PG13M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"gpt_icon":0},{"id":"2514002529","title":"FDA Accepts Bla for Tlx250-Cdx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2514002529","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514002529?lang=en_us&edition=fundamental","pubTime":"2025-02-26 07:51","pubTimestamp":1740527484,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nTUA9TTZCJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","TLX.AU"],"gpt_icon":0},{"id":"2514111028","title":"Telix Pharmaceuticals Ltd - FDA Accepts Bla and Grants Priority Review for Zircaix","url":"https://stock-news.laohu8.com/highlight/detail?id=2514111028","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514111028?lang=en_us&edition=fundamental","pubTime":"2025-02-26 06:59","pubTimestamp":1740524366,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG13M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLX.AU","BK7067"],"gpt_icon":0},{"id":"2514042166","title":"Telix Pharmaceuticals Ltd - Tiffany Olson to Be Appointed Board Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2514042166","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514042166?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:52","pubTimestamp":1740520348,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG162:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLX.AU","BK7067"],"gpt_icon":0},{"id":"2514004215","title":"Telix Pharmaceuticals Ltd -  H Kevin Mccann Ao Will Retire as Board Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2514004215","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514004215?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:52","pubTimestamp":1740520348,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG162:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLX.AU","BK7067"],"gpt_icon":0},{"id":"2514095557","title":"Recruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical NOW Active in Miami","url":"https://stock-news.laohu8.com/highlight/detail?id=2514095557","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514095557?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:30","pubTimestamp":1740486600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nTUA75TDFN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","TLX.AU"],"gpt_icon":0},{"id":"2514065098","title":"Illuccix® Prostate Cancer Imaging Agent Approved in Luxembourg","url":"https://stock-news.laohu8.com/highlight/detail?id=2514065098","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514065098?lang=en_us&edition=fundamental","pubTime":"2025-02-25 17:49","pubTimestamp":1740476940,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nTUA3TX8NB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","TLX.AU"],"gpt_icon":0},{"id":"2514068089","title":"Telix Pharmaceuticals Shifts Reporting Currency to US Dollars; Shares Hit All-Time High","url":"https://stock-news.laohu8.com/highlight/detail?id=2514068089","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514068089?lang=en_us&edition=fundamental","pubTime":"2025-02-25 09:31","pubTimestamp":1740447116,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  will change its reporting currency to US dollars from Australian dollars, effective Jan. 1, according to a Tuesday Australian bourse filing.The change allows the company to align to the predominant currency used for reporting revenue, costs, and corresponding cash flows, which are primarily generated in the US, the filing added.The company will also convert the comparative periods in upcoming financial results to US dollars, per the filing.The company's shares fell almost 1% in recent Tuesday trade but earlier hit an all-time high.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XKO.AU","TLX.AU","XJO.AU","TLX","XAO.AU","BK7067"],"gpt_icon":0},{"id":"2514089127","title":"BRIEF-Telix Pharmaceuticals Announces Change In Reporting Currency To USD","url":"https://stock-news.laohu8.com/highlight/detail?id=2514089127","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514089127?lang=en_us&edition=fundamental","pubTime":"2025-02-25 09:27","pubTimestamp":1740446856,"startTime":"0","endTime":"0","summary":"BRIEF-Telix Pharmaceuticals Announces Change In Reporting Currency To USDFeb 25 (Reuters) - Telix Pharmaceuticals Ltd TLX.AX:TELIX ANNOUNCES CHANGE IN REPORTING CURRENCY TO USDFurther company coverage: TLX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PF1W1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"gpt_icon":0},{"id":"2514498709","title":"Telix Pharmaceuticals Ltd - Telix Announces Change in Reporting Currency to USD","url":"https://stock-news.laohu8.com/highlight/detail?id=2514498709","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514498709?lang=en_us&edition=fundamental","pubTime":"2025-02-25 05:42","pubTimestamp":1740433361,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nFWN3PF1W1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLX.AU","BK7067"],"gpt_icon":0},{"id":"2514077132","title":"BUZZ-Telix up as Norway approves its prostate cancer imaging agent","url":"https://stock-news.laohu8.com/highlight/detail?id=2514077132","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514077132?lang=en_us&edition=fundamental","pubTime":"2025-02-25 01:24","pubTimestamp":1740417882,"startTime":"0","endTime":"0","summary":"BUZZ-Telix up as Norway approves its prostate cancer imaging agent** U.S.-listed shares of Australia's Telix Pharmaceuticals TLX.AX, TLX.O up 30% at $25.33** Co says the Norway's regulatory authority ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3N3PF19L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"gpt_icon":0},{"id":"2514727027","title":"Telix Pharmaceuticals Limited (TLX) Upgraded to Buy: What Does It Mean for the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514727027","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514727027?lang=en_us&edition=fundamental","pubTime":"2025-02-25 01:00","pubTimestamp":1740416413,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals Limited  could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 . This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time.Therefore, the Zacks rating upgrade for Telix Pharmaceuticals Limited basically reflects positivity about its earnings outlook that could translat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/telix-pharmaceuticals-limited-tlx-upgraded-170013791.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TLX","TLX.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739919600000,"name":null,"time":"","dateTimestamp":1739883600000,"actualEps":null},{"date":"2024-08-22","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724284800000,"name":null,"time":"","dateTimestamp":1724248800000,"actualEps":null},{"date":"2024-02-22","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1708556400000,"name":null,"time":"","dateTimestamp":1708520400000,"actualEps":null},{"date":"2023-10-18","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1697583600000,"name":null,"time":"","dateTimestamp":1697547600000,"actualEps":null},{"date":"2023-08-23","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692748800000,"name":null,"time":"","dateTimestamp":1692712800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX.AU\",market:\"AU\",,,undefined,":[]}}